Connect with us

Technology

ALZpath Proprietary pTau217 Antibody Named to TIME’S List of the Best Inventions of 2024

Published

on

CARLSBAD, Calif., Oct. 30, 2024 /PRNewswire/ — ALZpath, Inc., a leading developer of innovative diagnostic tools and solutions for Alzheimer’s disease and related dementias, today announced that it has been honored in TIME’s annual Best Inventions list, which features 200 extraordinary innovations changing our lives. The ALZpath proprietary pTau 217 antibody was recognized in the medical care category for its ability to accurately diagnose Alzheimer’s disease.

The ALZpath proprietary antibody, used in blood-based assays, has displayed high diagnostic accuracy, sensitivity, and reliability in detecting very minute concentrations of phosphorylated tau (pTau217), a key biomarker for the diagnosis of Alzheimer’s disease in its earliest stages, before symptoms appear, and to track its progression over time.

“ALZpath is democratizing access through accessible blood tests for the 139 million people projected to have Alzheimer’s disease by 2050,” said Chad Holland, CEO of ALZpath. “With strategic partnerships, ALZpath’s antibody can be used in a variety of highly sensitive instruments for clinical and research blood assays and is integrated into the most widely available testing platforms.”

To compile this year’s list, TIME solicited nominations from TIME editors and correspondents around the world, and through an online application process, paying special attention to growing fields—such as health care, AI, and green energy. TIME then evaluated each contender on a number of key factors, including originality, efficacy, ambition, and impact.

Of the new list, TIME’s editors write: “The result is a list of 200 groundbreaking inventions (and 50 special mention inventions)—including the world’s largest computer chip, a humanoid robot joining the workforce, and a bioluminescent houseplant—that are changing how we live, work, play, and think about what’s possible.”

See the full list here: time.com/best-inventions-2024

About ALZpath

ALZpath is a leading developer of innovative diagnostic tools and solutions for Alzheimer’s disease and related dementias. The novel ALZpath pTau217 antibody, integral to the most advanced, widely available blood-based tests to detect Alzheimer’s disease, is transforming its diagnosis and treatment monitoring, providing accurate and accessible tools for researchers and healthcare professionals worldwide. To help millions of patients in need, ALZpath democratizes access to its proprietary robust antibody, which is used by researchers, clinicians, and industry partners around the world to accelerate the discovery of new treatments and improve patient care.

To learn more about the company, please visit https://alzpath.bio/ and follow us on LinkedIn.

ALZpath Media Contact:

Nechama Rosengarten
FINN Partners
nechama.rosengarten@finnpartners.com

Photo – https://mma.prnewswire.com/media/2544534/ALZpath_TIMES_Best_Inventions_2024.jpg

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alzpath-proprietary-ptau217-antibody-named-to-times-list-of-the-best-inventions-of-2024-302291662.html

SOURCE ALZpath, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CREW Carbon raises $5.3mm seed round to capture carbon at wastewater treatment facilities

Published

on

By

Counteract Partners leads funding to scale CREW Carbon’s commercial operations with existing wastewater treatment partners, while expanding their technology to additional plants

BROOKLYN, N.Y., Oct. 30, 2024 /PRNewswire/ — In order to meet global climate targets, ~10 gigatons of carbon dioxide needs to be removed from the atmosphere annually by 20501. CREW Carbon is on a mission to leverage its enhanced weathering approach within earth’s water cycle, focused initially on removing biogenic CO2 produced in wastewater treatment facilities. Significant amounts of CO2 are naturally concentrated within wastewater, creating an ideal environment to rapidly scale carbon removal. Developed through years of research at Yale University, CREW’s technology enhances the natural power of minerals to treat wastewater and store CO2 permanently, all while removing the cost barrier to optimize biological treatment in wastewater. The company is already operating at multiple plants and are on their way to scaling operations to remove thousands of tons next year.  Seed funding will enable CREW to grow the team, deploy systems at additional wastewater plants, and continue building their proprietary carbon monitoring, reporting, and verification (MRV) system.

The oversubscribed round was led by Counteract and included participation by ReGen Ventures, ANIMO, Connecticut Innovations, Ponderosa Ventures, Newlab, Echo River Capital, and the Carbon Drawdown Initiative.

“Robust greenhouse gas removal is needed, and needed swiftly, to limit the effects of climate change and to meet our climate goals,” said Dr. Joachim Katchinoff, CREW Co-Founder and CEO. “CREW has identified that water resource recovery facilities are one of the best locations for rapid carbon removal. As a society we have spent decades building amazing wastewater treatment infrastructure to keep our environment safe; now, with CREW’s technology, we can work with utility and industrial partners to supplement their treatment processes in a way that can measurably remove CO2 at scale while enabling safe and efficient wastewater treatment.”

The solution is resonating with investors, who see it as a scaleable, affordable way to address the climate problem. Andy Bonsall, Partner at Counteract who led the round and specializes in backing solutions for gigaton-scale carbon removal, said “We’re thrilled about CREW’s game-changing technology that scales measurable carbon removal while simultaneously delivering key improvements for wastewater facilities. By partnering with wastewater treatment plants, who are already important stewards of our communities and environment, CREW is tapping into existing infrastructure and keeping costs of deployment low. It’s a win for municipalities, industry, and our journey to net-zero, solving long standing challenges with a demonstrated, low-cost solution.”

Given the co-benefits for wastewater treatment operators, “CREW’s solution is an easy sell to partners in the wastewater sector,” according to Chris Morrison, Executive in Residence at ImagineH2O and former Division Vice President of Water Process Services at Ecolab/Nalco. “The CREW technology is sound – their pilots to date have achieved their goals of reducing costs and improving pH and alkalinity management. The technology is safer than existing solutions – removing harmful chemicals like caustic from operations. And the technology is innovative – it’s truly a first of a kind solution that transforms wastewater treatment plants into climate hubs. It’s a paradigm shift for the industry.”

About CREW

CREW Carbon is a carbon removal company that uses engineered enhanced weathering to remove CO2 from municipal and industrial wastewater systems. CREW’s technology enhances the natural power of minerals to help treat wastewater and store carbon dioxide permanently. CREW partners with wastewater treatment plants, leveraging existing infrastructure to enable measurable climate impact while simultaneously helping optimize biological treatment.

 References

CDR Primer, The Case for Carbon Dioxide Removal, 2024

Media Contact: Jo Katchinoff, joachim@crewcarbon.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/crew-carbon-raises-5-3mm-seed-round-to-capture-carbon-at-wastewater-treatment-facilities-302290695.html

SOURCE CREW Carbon

Continue Reading

Technology

Corelight Included on Fortune Cyber 60 List of Fastest-Growing Private Cybersecurity Companies

Published

on

By

SAN FRANCISCO, Oct. 30, 2024 /PRNewswire/ — Corelight, the leader in open network detection and response (NDR) solutions, today announced it has been named to the Fortune Cyber 60 list, presented by Lightspeed, a listing of the most important venture-backed startups that offer enterprise-grade cybersecurity solutions. Corelight was added to the growth stage companies category and is the only company providing NDR solutions included on the list.

“Corelight is on this list because defenders need insight across the kill chain,” said Brian Dye, Corelight CEO. “Attackers can’t hide from the network. Corelight mines the network to provide customers with ground truth evidence detailing all activity traversing the network to identify and disrupt increasingly sophisticated threats.”

Corelight secured its spot on the Fortune Cyber 60 because of its exceptional growth in the market. Earlier this year, the company raised a $150 million Series E investment led by its first capital investor, Accel, with additional strategic investment from Cisco Investments and CrowdStrike Falcon Fund.  In addition, Corelight is the NDR platform of choice for the elite cybersecurity services teams at CrowdStrike, Mandiant, and the Black Hat NOC at Black Hat events. Corelight’s technology and partnerships have propelled the company to becoming the industry’s fastest-growing, scaled NDR platform, with more than 40% YoY ARR growth and 300% YoY growth in the company’s AI and SaaS-driven NDR solutions.

Corelight’s key differentiators continue to set it apart from competitors:

Open Source Heritage – Corelight was founded by the same individuals who created the Zeek open source network security monitoring tool. Its commercial Intrusion Detection System (IDS) solution is powered by Suricata, giving customers a much richer set of insights that are continuously augmented by the community.Robust Detection Coverage – Corelight leverages all available detection options to ensure that customers can leverage the best tool for the job. In addition to ML/AI, Corelight offers behavioral, signature, threat intelligence, and query-based detections.Alerts + Evidence Strategy – Corelight has the deepest, most complete set of network evidence/insights that can be automatically fused with alerts to provide immediate insight and actionability.Approach to Packet Capture (PCAP) – Corelight’s Smart PCAP allows customers to select only the packets they need for a particular exercise (threat hunting, investigations, etc.), giving customers the ability to store much more data (months or years vs. days and weeks) cost-effectively and have longer lookback windows.

The 2024 Fortune Cyber 60 list is published here: https://fortune.com/ranking/cyber/. This list was co-created by Lightspeed Venture Partners and Fortune magazine based on an analysis of more than 500 cybersecurity organizations.

About Corelight
Corelight transforms network and cloud activity into evidence that security teams use to proactively hunt for threats, accelerate response to incidents, gain complete network visibility and create powerful analytics. Corelight’s global customers include Global 2000 companies, major government agencies, and large research universities. Based in San Francisco, Corelight is an open-core security company founded by the creators of Zeek®, the widely-used network security technology. For more information, visit https://corelight.com or follow @corelight_inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/corelight-included-on-fortune-cyber-60-list-of-fastest-growing-private-cybersecurity-companies-302291762.html

SOURCE Corelight

Continue Reading

Technology

Bellin Health and Protera Health Launch Partnership to Deliver Virtual Integrated Musculoskeletal (MSK) Health Care for Qualified Health System Employees

Published

on

By

DETROIT and GREEN BAY, Wis., Oct. 30, 2024 /PRNewswire/ — Bellin Health (Green Bay, WI), an integrated non-profit healthcare system and a national leader in value-based health care, has partnered with Protera Health, a value-based virtual MSK integrated clinic formed out of a partnership with Henry Ford Health Innovations (Detroit, MI), to deliver cutting-edge virtual MSK care to its self-insured health system employees.  This partnership brings Protera Health’s integrated practice unit (IPU) solution directly into the health system’s employee wellness and benefits program.  

“We chose Protera Health over a number of other digital MSK solutions because of the strength of their clinical model.”

“Each year, MSK is among our most frequently encountered employee health conditions.  It was very important for us to find a digital solution that could deliver high-quality care to all of our qualified employees and dependents,” explained Chris Elfner, VP of Accountable Care for Bellin and Gundersen Health System, becoming Emplify Health.

Protera Health’s virtual IPU – based on a decade of clinical transformation and research – is specifically designed to not only improve health outcomes but also to reduce costs of care.  This model centers on physician-led multidisciplinary care, individualized treatment according to patient reported outcome measures (PROMs), and connection to health system services when clinically appropriate.  Alongside telehealth visits with the Protera clinical team, participants engage with an individualized web portal for home exercises, educational videos, and health outcome scores, all of which further improve lifestyle and behavior.

“We chose Protera Health over a number of other digital MSK solutions because of their commitment to being a true partner for our health system and because of the strength of their clinical model.  They also were willing to be creative and solutions-oriented to ensure high quality delivery and outcomes.  Due to the initial success of the rollout, we have already planned numerous health system expansion pathways through which we plan to deploy Protera,” said Dr. Joseph Kucksdorf, Bellin Physical Therapist and Clinician Leader.

The partnership, which launched in April 2024, provides qualified Bellin employees with access to Protera Health services at no cost.  This benefit is an extension of existing no-cost physical therapy access for these employees through Bellin Physical Therapy.  Upon enrollment, employees with MSK conditions undergo virtual treatment by the multidisciplinary, physician-led Protera Health Care Team, with access to personalized education, exercises, and health services through the Protera Health web portal.  Rigorous clinical outcomes – including those of physical, mental, and pain health – are monitored throughout the partnership.     

“Bellin Health is one of the most innovative healthcare systems in the country,” noted Dr. Eric Makhni, orthopedic surgeon and CEO/Co-Founder of Protera Health. “We are excited to be an extension of their already excellent MSK care and best-in-class benefits infrastructure.”

About Protera Health
Protera Health (Troy, MI) improves health outcomes and lowers costs of care for musculoskeletal (MSK) conditions through a multidisciplinary, virtual approach.  The virtual clinic, which can provide services through in-network value-based contracting, partners with health insurance plans, health systems, and employers.  Protera Health launched in partnership with Henry Ford Health Innovations and is founded by a team of clinician experts in value-based MSK care.

About Bellin Health
Bellin Health is an integrated healthcare delivery system based in Green Bay, Wis. It has served people in Northeast Wisconsin and Michigan’s Upper Peninsula since 1908. Bellin Health has more than 5,500 employees and is known for its emphasis on preventive healthcare and is a leader in cardiac, orthopedics, sports medicine, digestive health, mental health and primary care medicine. In late 2022, Bellin completed a merger of equals with La Crosse, Wis.-based Gundersen Health System, providing access to more resources and a broader network of services for the patients and communities they serve. In April 2024, Bellin and Gundersen Health System announced it is becoming Emplify Health, a new name and brand to advance its commitment to patients and community.  

Media contact: 
Protera Health 
info@proterahealth.com
810-331-0939
www.proterahealth.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bellin-health-and-protera-health-launch-partnership-to-deliver-virtual-integrated-musculoskeletal-msk-health-care-for-qualified-health-system-employees-302291529.html

SOURCE Protera Health

Continue Reading

Trending